PodcastRx with Chris Bender: October 2024

October is American Pharmacist Month, and to help recognize the many ways pharmacists care for communities, we talk to Chris about the influence and increasing importance of the clinical pharmacist in correctional and institutional healthcare settings. Chris details the primary strategies he and the OPTICS team use to impact patient care, reflects on the evolution of the clinical pharmacist role, explains how providers can better take advantage of pharmacist knowledge, and more.

‍

We also go “Into the Clinic” to talk medication news (including the recent approval of Cobenfy for schizophrenia), and, in anticipation of Halloween, look at the real connections between pharmacy and witchcraft in our Trivia Capsule segment.

‍

Subscribe and listen on any major podcast platform, or listen right here.

‍

Links to material discussed in each segment:

‍

"Into the Clinic"

FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size Indices

The FDA Approval of Cobenfy: A Historic Moment in Schizophrenia

For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's been

FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

‍‍

Trivia Capsule:

Witches, potions, and metabolites: an overview from a medicinal perspective

‍

‍

‍

‍

‍

‍

‍